Effects of Glucagon-Like Peptide 1 (7–36 Amide) on Glucose Kinetics during Somatostatin-Induced Suppression of Insulin Secretion in Healthy Men

Publisher： Karger

E-ISSN： 1663-2826|49|5|221-225

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.49, Iss.5, 1998-04, pp. : 221-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms Involved in Glucagon-Like Peptide-1 (7–36) Amide Action on the Rat Hypothalamo-Neurohypophysial System

By  

Neuroendocrinology, Vol. 77, Iss. 2, 2003-03 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 54-58

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2012-12 ,pp. : 300-308

Karger

Access to resources Recommend Favorite

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-02 ,pp. : 815-825

Karger

Access to resources Recommend Favorite